The study found that the incubation period of the virus was five days for all but one of the patients, and the average duration of symptoms was eight days. However, the length of time that patients remained contagious after resolution of their symptoms ranged from one to eight days.
ACE inhibitors and Angiotensin Receptor Blockers May Increase Mortality Rate In Elderly COVID-19 Patients
These highly prescribed medications change cell surface protein expression, which is particularly problematic in cells in the respiratory system—tissue that is vulnerable to targeting and attack by the COVID-19 virus.
As Moderna's vaccine development moves at unprecedented speed, the company's CEO explains how they have moved so quickly and why he is hopeful that their pace will continue.
The researchers explain why it is an urgent matter for environmental engineers and scientists to collaborate on pinpointing viral and environmental characteristics that affect COVID-19 transmission via surfaces, the air, and fecal matter.
Company expects to deliver 50,000 tests per day of the rapid, instrument-based, isothermal system designed for qualitative detection of infectious diseases.
The tool indicated that a combination of small changes in levels of the liver enzyme alanine aminotransferase (ALT), patient-reported myalgia (aching muscles), and raised hemoglobin levels, most accurately predicted the development severe disease.
The study used four adult Chinese rhesus macaques and found that those monkeys that had been re-exposed to SARS-CoV-2, like the unexposed control monkey, showed no recurrence of COVID-19.
COVID-19 Compass is based on CDC guidelines, best clinical practices, illness severity, and risk factors such as age, gender, location, potential exposure and pre-existing health conditions.
Researchers will launch the study involving 1,000 subjects—consisting of COVID-19 patients and their partners and first-degree relatives as controls—to compare a variety of genomic and other biological variables between those patients who show no or mild symptoms and those who show severe illness.
C3.ai DTI will focus its research on AI, machine learning, the internet of things, big data analytics, human factors, organizational behavior, ethics, and public policy.
The collaboration will provide a COVID-19 test offering that combines Paragon Genomics' CleanPlex SARS-CoV-2 NGS panel reagent kit for whole-genome sequencing of the coronavirus with the advanced analytical power of the SOPHiA platform.
The research reveals that the LY6E protein impairs the coronavirus’ ability to initiate infection, which could lead to treatments for the illness.
Under the EUA designation, the Primerdesign test is authorized only for the detection of RNA from SARS-CoV-2 virus and diagnosis of SARS-CoV-2 virus infection, and not for any other viruses or pathogens.
Gardnerella bacteria were the dominant biomarker for the progression of HR-HPV and its effect is mediated by increased cervicovaginal bacterial diversity directly preceding the progression of a persistent infection to precancer.
From polygenic risk scores and CRISPR to immune therapies and mapping human cells, our inaugural selection of young scientists underscores the breadth of precision health research.
A notable addition to the effort is a team from the University of Birmingham, led by Nick Loman, Ph.D., professor of Microbial Genomics and Bioinformatics in the Institute of Microbiology and Infection, whose lab is known for fusing cutting-edge sequencing with microbial genomics.
The study could signal a potential treatment breakthrough for patients with this form of breast cancer, which disproportionately affects and tends to develop more aggressively in black women.
Scripps researchers compare available genome sequence data for known coronavirus strains to determine that that SARS-CoV-2 originated through natural processes and note that their results “clearly show that SARS-CoV-2 is not a laboratory construct or a purposefully manipulated virus.”
GenapSys’ sequencing system is about the size of an iPad, costs under $10,000, and is based on a proprietary direct electronic sequencing chip, which is intended to eliminate the need for cumbersome equipment.
The enzyme Carnitine Palmitoyltransferase 1A (CPT1A) may control how much fat ovarian cancer cells can burn, suggesting a treatment that limits these cells’ access to CPT1A may starve them of the resources they need to spread.
Using mouse models of malignancy, researchers at UT Southwestern Medical Center and the University of Chicago have implicated the gut microbiome in the success of immunotherapies. The researchers suggest that gut bacteria can penetrate tumor cells and boost the effectiveness of an experimental immunotherapy that targets the CD47 protein.
Emergency Use Authorization (EUA) would enable Biodesix and Bio-Rad to begin testing in the U.S. using the Droplet Digital PCR system.
New research demonstrates that taking EGR4 away promotes the activation of killer T cells, which infiltrate and attack tumors and thereby boost anticancer immunity.
The companies will partner on a proof-of-concept project focused on detection of SARS-CoV-2 coronavirus as the first initiative of a broader collaboration focused on developing molecular diagnostic tests for infectious diseases and oncology.
Hunt Willard signs on as chief science officer and VP of medical affairs, and Erica Ramos as VP of population genomics.